Clinical trial NCT06589414: Reintegrating a Systematic Review Consultation With the General Practitioner After the Cancer Diagnosis Has Been Announced Into the Complex Cancer Patient Pathway: Feasibility Study
Official title: Reintegrating a Systematic Review Consultation With the General Practitioner After the Cancer Diagnosis Has Been Announced Into the Complex Cancer Patient Pathway: Feasibility Study
Study type: INTERVENTIONAL
Overall status: RECRUITING
Phase: NA
Conditions: Solid Tumours
Keywords: Solid Tumours
Announcement system
General practitioner
Lead sponsor: Institut Claudius Regaud
Sponsor class: OTHER
Collaborators: name: Ligue contre le cancer, France
First posted: 2024-09-19
Enrollment: 171
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: NA
Intervention model: SINGLE_GROUP
Primary purpose: HEALTH_SERVICES_RESEARCH

Brief summary: This is a prospective, multicentric, regional study designed to assess the feasibility of setting up a summary consultation with a general practitioner (GP) to complement the consultation for the announcement of a cancer diagnosis.

171 patients will be included in the study.

Each patient will be followed for 6 months.


Eligibility criteria: Inclusion Criteria:

1. Age ≥ 18 years.
2. Patient with a solid tumour whatever the organ.
3. Patient treated in one of the participating centres as part of a system for announcing the diagnosis of a solid cancer.
4. Patient undergoing cancer treatment in one of the participating centres.
5. Patient with a registered general practitioner in the Occitanie region.
6. Patient affiliated to a French Social Security scheme.
7. Patient having signed informed consent prior to inclusion in the study and prior to any specific procedure for the study.

Exclusion Criteria:

1. Patient already included in another clinical trial concerning a care pathway.
2. Patient deprived of liberty or under legal protection (curatorship and guardianship, safeguard of justice).
3. Pregnant or breast-feeding woman.

Primary outcomes:
measure: The ratio between the number of patients who attended the summary consultation with the general practitioner within 15 days of being diagnosed with cancer in the referral care centre and the total number of patients included in the study.
timeFrame: 19 months after the start of the study
Secondary outcomes:
measure: The reasons why the summary consultation with the GP did not take place within 15 days of the consultation to announce the cancer diagnosis.
timeFrame: 19 months after the start of the study
measure: The type of consultations carried out with the GP (physical consultations, teleconsultations or home visits) will be presented as follows, using standard descriptive statistics.
timeFrame: 19 months after the start of the study
measure: The number of cancellations of consultations with GPs will be presented as follows, using standard descriptive statistics.
timeFrame: 19 months after the start of the study
measure: The number of postponed consultations with the GP will be presented as follows, using standard descriptive statistics.
timeFrame: 19 months after the start of the study
measure: The overall compliance will be presented as follows, using standard descriptive statistics.
timeFrame: 19 months after the start of the study
measure: The participation will be assessed.
timeFrame: 19 months after the start of the study
measure: The socio-demographic characteristics of the patients included will be described and analysed.
timeFrame: 19 months after the start of the study
measure: The rate of patients with a change in management between the treatment proposed at the RCP (Multidisciplinary Consultation Meeting) and that carried out in the centre.
timeFrame: 19 months after the start of the study
measure: The number of hospital admissions and unscheduled consultations at the referral centre during the 6 months of follow-up will be assessed for each patient included in the study.
timeFrame: 6 months for each patient
measure: The satisfaction of patients included in the study and of GPs whose patients take part in the study.
timeFrame: 19 months after the start of the study
Other outcomes:
Locations:
city: Auch
country: France
facility: CH Auch
city: Toulouse
country: France
facility: CHU Larrey
city: Toulouse
country: France
facility: CHU Rangueil
city: Toulouse
country: France
facility: Institut Universitaire du Cancer de Toulouse - Oncopole
Study officials:
References: